Crown Bioscience International is a leading provider of cutting-edge preclinical and translational research services, committed to advancing drug discovery and development. Our comprehensive suite of services includes state-of-the-art biomarker discovery to identify and validate biomarkers, DMPK services for in-depth analysis of drug metabolism and pharmacokinetics, and a wide range of laboratory services for accurate and reliable results. We offer robust pharmacology and bioanalytical services to support drug quantification and biomarker analysis, thorough toxicology assessments to ensure drug safety, and rigorous efficacy testing to evaluate therapeutic potential. Additionally, our high-throughput screening services help identify and characterize lead compounds quickly. At Crown Bioscience International, we are dedicated to providing high-quality, reliable, and timely research services to support your drug discovery and development programs. Partner with us to leverage our expertise and state-of-the-art technologies to bring your innovative therapies to market faster. Contact us today to learn more about how we can support your research needs.